IP Library › Granted Patent US 9,933,429
Granted Patent B2
US 9,933,429 · App. 13/256,630 · Granted Apr 3, 2018

Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof

Inventors: Sung H Baek (Snohimish, WA); Robert T. Streeper (San Antonio, TX); Elzbieta Izbicka (San Antonio, TX)
Assignee: Cancer Prevention and Cure, LTD.
G01N33/57423
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,933,429
App. No.
13/256,630
Granted
Apr 3, 2018
Kind
B2
Abstract

The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-small cell lung cancer or reactive airway disease. The invention also provides methods of differentiating lung disease, methods of monitoring therapy, and methods of predicting a subject's response to therapeutic intervention based on the extent of expression of the biomarkers and combinations of biomarkers. Kits comprising agents for detecting the biomarkers and combination of biomarkers are also provided.

Claims (11)

1. A method of measuring a subset of biomarkers by immunoassay in a subject comprising

(a) obtaining a physiological sample from the subject,

wherein the physiological sample is blood, serum, or plasma; and

(b) measuring in the sample a set of at least six biomarkers selected from the group consisting of MCP-1, MPO, HGF, MMP-9, MMP-7, SAA, Resistin, IL-5, Leptin, IL12 (p70), IL-8, IL-4, IL-10, IL-7, MIF, sCD40 ligand, sICAM-1, or a combination thereof, by immunoassay.

2. The method of claim 1 , wherein the subject is a human male.

3. The method of claim 1 , wherein the subject is a human female.

4. The method of claim 1 , wherein the measuring comprises performing a quantitative multiplex immunoassay.

5. The method of claim 1 , wherein the subject is a mammal.

6. The method of claim 5 , wherein the mammal is a human.

7. The method of claim 1 , wherein the method comprises measuring a set of at least seven, eight, or nine of the biomarkers.

8. The method of claim 1 , wherein the method further comprises measuring at least one biomarker selected from the group consisting of IL-13, 1-TAC, MMP-1, Eotaxin, IP-10, sVCAM-1, Adiponectin, CRP, C-Peptide, MMP-3, SAP, IL-1ra, IL-15, EGF, MMP-8, IL-6, MMP-12, PAI-1, Amylin (Total), IL-1α, sFS1, MIP-1β, SE-selectin, IL-17, GM-CSF, G-CSF, TGF-α, IFN-γ, Fractalkine, VEGF, IL-12 (p40), Sfas, IL-1β, IL-2, MIP-1α, Insulin, GLP-1, TNF-α, MMP-2, MMP-13, IL-12(p40), free, I-TAC, or a combination thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2022
From: CANCER PREVENTION AND CURE, LTD
To: LUNG CANCER PROTEOMICS LLC
Reel/Frame 061742/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2012
From: BAEK, SUNG H.
To: CANCER PREVENTION AND CURE, LTD.
Reel/Frame 028755/0643 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2012
From: STREEPER, ROBERT T.; IZBICKA, ELZBIETA
To: CANCER PREVENTION AND CURE, LTD.
Reel/Frame 028755/0751 →
Continuity (7)
Division 12403369 · Mar 12, 2009
Continuation In Part 12208437 · Sep 11, 2008
Continuation In Part 12208876 · Sep 11, 2008
Provisional Application 60971440 · Sep 11, 2007
Provisional Application 60971422 · Sep 11, 2007
Provisional Application 61237198 · Aug 26, 2009
Related Publication 20120302455A1 · Nov 29, 2012